2020 highlights

Ethical
standards

22

Ethical commitments

included in our new Code of Ethics, co-created with more than 3 000 Novartis associates

Access to
healthcare

66 m

Patients

reached with products through our access activities

Global
health

980 m

Treatment courses

of Coartem delivered in the past two decades in malaria-endemic countries

Responsible
citizenship

19%

Reduction

in greenhouse gas emissions vs. 2016 baseline

See all highlights

Who we are

We reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues.

Learn more
Novartis company structure (Graphic)

How we create value

In a rapidly changing business environment, our strategy and business model help us deliver on our purpose and create value for our company and society.

Learn more

At a glance

Our response to COVID-19

In the face of a global crisis, Novartis quickly mobilized research and development capabilities, medicines, clinical trial expertise and philanthropic aid to address the COVID-19 pandemic.

Read

Key figures comparison

The interactive key figures comparison lets you compare key values over the past two years.

Novartis key performance indicators (Graphic) View data

Annual Reporting Suite

Read and download PDF versions of the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG Report.

Digital reporting homepage (Photo) Read more